Progress Software Corporation ( PRGS) Discusses High-Performance Multi-Database Connectivity and WinSQL Features May 7, 2026 1:00 PM EDT ...
OpenAI is making several updates to its Codex AI coding agent. Codex is now able to operate desktop Mac apps with its own cursor, seeing what's on the screen, clicking, and typing to complete tasks.
Codex can now use your macOS apps on its own. Codex will now be able to operate desktop apps on your computer, OpenAI says in a blog post announcing the update. It can work in the background, meaning ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. All your photos are now in play. Updated on Apr. 20 with additional analysis on Google’s new ...
Codex Desktop expands from coding into full productivity workflows. Automation can generate images, charts, and workflow outputs. The tool is still aimed at developers despite the broader productivity ...
Confirming it has reached 3 million weekly developers, OpenAI is massively updating its Codex developer environment via its Mac and Windows desktop apps today to bring it closer to the “Super App” the ...
Google announced on Thursday that it’s rolling out a new way to explore the web with AI Mode, its conversational search experience. Now, when you’re using AI Mode on Chrome desktop, clicking a link ...
Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Eric's career includes extensive work in both public and ...
Joe Walsh is a senior editor for digital politics at CBS News. Joe previously covered breaking news for Forbes and local news in Boston. Defense Secretary Pete Hegseth and Chairman of the Joint Chiefs ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...
Venous thromboembolism in patients on check point inhibitors. A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results